IGF-II Producing Hepatocellular Carcinoma Treated with Sorafenib: Metabolic Complications and a Foresight to Molecular Targeting Therapy to the IGF Signal

Hypoglycemia is a rare paraneoplastic manifestation of patients with neoplasms. Hypoglycemia can be induced by several causes, including an aberrant increase of hypoglycemic agents and adrenal insufficiency. Sorafenib is the first agent to demonstrate a survival benefit in the treatment of advanced...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Okushin, Kazuya, Asaoka, Yoshinari, Fukuda, Izumi, Fujiwara, Naoto, Minami, Tatsuya, Sato, Masaya, Mikami, Shintaro, Uchino, Koji, Enooku, Kenichiro, Kondo, Yuji, Tateishi, Ryosuke, Goto, Tadashi, Shiina, Shuichiro, Yoshida, Haruhiko, Koike, Kazuhiko
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2012
Matèries:
Published online: December, 2012
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3551420/
https://ncbi.nlm.nih.gov/pubmed/23341802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000346462
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars